Takahiro Tsuno
Maebashi, 3718512, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.
Journal: Metabolism: clinical and experimental
Published: January 20, 2026
Characterization of extracellular and membrane potentials in imeglimin-treated islets.
Journal: Journal of diabetes investigation
Published: September 06, 2025
Regulatory Roles of IGF2R in Insulin Secretion and Adaptive β-Cell Proliferation.
Journal: Diabetes
Published: March 03, 2025
Imeglimin suppresses glucagon secretion and induces a loss of α cell identity.
Journal: Cell reports. Medicine
Published: December 10, 2024
Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells.
Journal: Diabetes
Published: November 29, 2024
The antitumor effects of metformin are potentially mediated through LPA receptor inhibition.
Journal: Diabetes research and clinical practice
Published: October 03, 2024
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 28, 2023
Encapsulated human islets in alginate fiber maintain long-term functionality.
Journal: Endocrine journal
Published: December 24, 2023
A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 02, 2023
Protective Effects of Imeglimin and Metformin Combination Therapy on β-Cells in db/db Male Mice.
Journal: Endocrinology
Published: January 08, 2023
Last Updated: 09/26/2026